C4 Therapeutics, Inc.
C4 Therapeutics is pioneering a new class of drugs. C4’s technology platform produces small molecule drugs that harness machinery already present in cells to selectively target disease-relevant proteins for degradation. Our approach has the potential to address a broad range of diseases including cancer, infectious disease, and autoimmune disorders.
biotechnology, cell biology, protein chemistry, cell pharmacology
Watertown, MA, United States